Cecilia Furlong analyst

Currently out of the existing stock ratings of Cecilia Furlong, 125 are a HOLD (57.08%), 87 are a BUY (39.73%), 7 are a SELL (3.2%).

Cecilia Furlong

Work Performance Price Targets & Ratings Chart

Analyst Cecilia Furlong, carries an average stock price target met ratio of 60.56% that have a potential upside of 19.66% achieved within 262 days. Previously, Cecilia Furlong worked at MORGAN STANLEY, CANACCORD.

Cecilia Furlong’s has documented 443 price targets and ratings displayed on 29 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on IRTC, iRhythm Technologies at 02-Dec-2025.

Wall Street Analyst Cecilia Furlong

Analyst best performing recommendations are on SWAV (SHOCKWAVE MEDICAL).
The best stock recommendation documented was for IRTC (IRHYTHM TECHNOLOGIES) at 1/7/2022. The price target of $129 was fulfilled within 3 days with a profit of $27.05 (26.53%) receiving and performance score of 88.44.

Average potential price target upside

ABT Abbott Laboratories ALC Alcon AG CRY CryoLife EW Edwards Lifesciences Corp SGHT Sight Sciences SWAV Shockwave Medical TMDX TransMedics Group VAPO Vapotherm BSX Boston Scientific Corp LUNG Pulmonx Corp BAX Baxter International DXCM DexCom IRTC iRhythm Technologies ISRG Intuitive Surgical NVRO Nevro Corp AORT Artivion BLCO Bausch + Lomb Corp EMBC Embecta Corp TFX Teleflex VRAY ViewRay MDT Medtronic PLC NARI Inari Medical SYK Stryker ZBH Zimmer Biomet Holdings ABMD ABIOMED ATRC AtriCure AXNX Axonics Modulation Technologies PODD Insulet IRT Independence Realty Trust

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 23-Jan-2017

$135

$37.5 (38.46%)

$135

27 days ago
(08-Sep-2026)

23/35 (65.71%)

$29.48 (27.94%)

340

Hold Since 13-Aug-2026

$130

$32.5 (33.33%)

1 months 22 days ago
(13-Aug-2026)

2/3 (66.67%)

$18.73 (16.83%)

29

Buy Since 28-Jul-2026

$125

$27.5 (28.21%)

$117

2 months 7 days ago
(28-Jul-2026)

3/4 (75%)

$17.73 (16.53%)

150

Buy Since 06-Jun-2019

$112

$14.5 (14.87%)

$136

2 months 18 days ago
(17-Jul-2026)

21/29 (72.41%)

$11.32 (11.24%)

409

Buy Since 19-Sep-2024

$118

$20.5 (21.03%)

$115

2 months 18 days ago
(17-Jul-2026)

4/8 (50%)

$17.32 (17.20%)

120

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?